FierceBiotechOriginal article
{"a":[{"_":"Lilly pens deal with Gateway Labs alumni Amplitude for RNA vaccine platform for infectious disease","$":{"href":"/biotech/lilly-licenses-amplitudes-rna-vaccine-platform-infectious-disease","hreflang":"en"}}]}
PartnershiptaRNA vaccinesPositive
AI Analysis
Summary
Eli Lilly has licensed a trans-amplifying RNA (taRNA) vaccine platform from Amplitude, a Gateway Labs alumni company, to develop vaccines for infectious diseases.
Importance:6/10
Sentiment:
0.50
partnershiplicensingRNA vaccineinfectious diseaseGateway Labs
Related Companies
Read the original article
Published by FierceBiotech on August 20, 2026 9:29 AM
